NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 155 filers reported holding NPS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,054,000 | +0.3% | 141,291 | -27.1% | 0.01% | -21.4% |
| Q3 2014 | $5,038,000 | -56.4% | 193,751 | -44.6% | 0.01% | -54.8% |
| Q2 2014 | $11,566,000 | +39.2% | 349,951 | +26.1% | 0.03% | +24.0% |
| Q1 2014 | $8,307,000 | -10.1% | 277,551 | -8.8% | 0.02% | -10.7% |
| Q4 2013 | $9,240,000 | +29.6% | 304,351 | +35.7% | 0.03% | +12.0% |
| Q3 2013 | $7,132,000 | +258.2% | 224,211 | +70.0% | 0.02% | +257.1% |
| Q2 2013 | $1,991,000 | -25.7% | 131,857 | -55.2% | 0.01% | -36.4% |
| Q4 2012 | $2,680,000 | – | 294,538 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|